Showing results (111-120 of 250) with videos related to
Sort By:
Pageof 25
Oncology (Williston Park, N.Y.)|February 24, 2001
Colorectal cancer: chemotherapy treatment overviewM E Royce, D Medgyesy, T H Zukowski, et al.Cancer Chemotherapy and Pharmacology|January 1, 1982
Vindesine: phase II evaluation in colon cancer and description of its platelet stimulating activityR Pazdur, A H Rossof, G Chandra, et al.The Cancer Journal From Scientific American|August 5, 1998
Phase II study of Taxol in patients with advanced gastric carcinomaJ A Ajani, J Fairweather, P Dumas, et al.Cancer Treatment Reports|November 1, 1976
Phase I study of oral mitomycin CS T Crooke, M Henderson, M Samson, et al.Cancer Treatment Reports|September 1, 1981
Phase II trial cisplatin, doxorubicin, and cyclophosphamide (CAP) in the treatment of urothelial transitional cell carcinomaM Campbell, L H Baker, M Opipari, et al.The American Journal of Medicine|June 1, 1995
Elevated plasma thrombopoietic activity in patients with metastatic cancer-related thrombocytosisZ Estrov, M Talpaz, G Mavligit, et al.Investigational New Drugs|April 1, 1992
Phase II trial of fazarabine in advanced colorectal carcinomaK P Hubbard, K Daugherty, J A Ajani, et al.Journal of the National Cancer Institute|July 20, 1994
Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagusJ A Ajani, D H Ilson, K Daugherty, et al.Cancer|March 10, 2001
Phase I bioequivalency study of MitoExtra and mitomycin C in patients with solid tumorsP Kozuch, P M Hoff, K Hess, et al.Annals of Surgery|March 17, 1999
Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancerA M Lowy, P F Mansfield, S D Leach, et al.Pageof 25